ANN ARBOR – MichBio U on July 28 will host a webinar to help its medical device makers enter key emerging markets quickly.
China has most likely passed from “emerging” status into a “must enter” status as it rapidly becomes the second largest health care market in the world. However, due to familiarity with the legal, regulatory, and business environments, many firms don’t look at China (or other key markets in Asia and Latin America) until after they enter the U.S. and Europe, even though these markets could represent larger opportunities than traditional markets.
This webinar will focus on what it takes to enter key emerging markets and discuss some of the strategies medical device companies can employ to get to market quickly.
Key topics will include:
Overview of emerging markets regulatory approval pathways
Significance of incorporating emerging markets into “Get-to-Market” strategy at an early stage
Legal, regulatory, and business strategies for speeding up access to emerging markets
Presenter: Seth J. Goldenberg, PhD, Senior Principal Scientist,NAMSA
Cost: This event is complimentary for MichBio members | Members register here
Non-member cost $29 | Register here
